Altra Holdings, Inc. (NASDAQ:AIMC) and Endocyte, Inc. (NASDAQ:ECYT) Added to Growing Stock Report's Nasdaq Gainers Watch List

New York, NY -- (SBWIRE) -- 02/19/2013 -- Growing Stock Report expands its Nasdaq Gainers Weekly Watch List adding Altra Holdings, Inc. (NASDAQ:AIMC) and Endocyte, Inc. (NASDAQ:ECYT)

Altra Holdings, Inc. (NASDAQ:AIMC) a company that through its subsidiary, Altra Industrial Motion, Inc. designs, produces, and markets a range of mechanical power transmission and motion control products worldwide closed up (+6.12%) during Friday's trading session on 255,499 shares traded after Altra Holdings Inc announced Q4 2012 Earnings and the stock hits 52-week high. Altra Holdings, Inc. (NASDAQ:AIMC) is currently up (+84.19%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Altra Holdings, Inc. (NASDAQ:AIMC)

Endocyte, Inc. (NASDAQ:ECYT) a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases closed up (+5.83%) during Friday's trading session on 182,283 shares traded. Endocyte, Inc. (NASDAQ:ECYT) is currently up (+197.94%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Endocyte, Inc. (NASDAQ:ECYT)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com